General Information of the Compound
Compound ID
CP0045086
Compound Name
4-Hydroxytamoxifen
    Show/Hide
Synonyms
(E/Z)-4-Hydroxy Tamoxifen
(Z)-4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-en-1-yl)phenol
(Z)-4-Hydroxytamoxifen
4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol
4-Hydroxytamoxifen
4-Monohydroxytamoxifen
4-OH-TAM
65213-48-1
68047-06-3
68392-35-8
95K54647BZ
Afimoxifene
BRN 4910749
C26H29NO2
CHEBI:44616
CHEMBL489
Hydroxytamoxifen
ICI 79,280
Ici 79280
MLS000069742
SMR000058939
TAMOXIFEN, 4-HYDROXY-, (Z)-
Tamogel
UNII-95K54647BZ
Z-4-hydroxytamoxifen
trans-4-Hydroxytamoxifen
    Show/Hide
Structure
Formula
C26H29NO2
Molecular Weight
387.523
Canonical SMILES
CC\C(=C(/c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25-
    Show/Hide
InChIKey
TXUZVZSFRXZGTL-QPLCGJKRSA-N
CAS
72732-26-4
68392-35-8
76276-99-8
65213-48-1
Physicochemical Property
logP
5.7017
Rotatable Bonds
8
Heavy Atom Count
29
Polar Areas
32.7
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 449459
SID: 14805025
ChEMBL ID
CHEMBL489
DrugBank ID
DB04468
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00886, Estrogen receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
IC50 = 0.79 nM
   TI
   LI
   LO
   TS
2
IC50 = 70 nM
   TI
   LI
   LO
   TS
CL000078 T-47D Homo sapiens (Human)  1
1
IC50 = 1.36 nM
   TI
   LI
   LO
   TS
CL000043 U2OS Homo sapiens (Human)  1
1
IC50 = 2.3 nM
   TI
   LI
   LO
   TS
CL000083 MCF-7 Homo sapiens (Human)  2
1
IC50 = 3 nM
   TI
   LI
   LO
   TS
2
IC50 = 10.2 nM
   TI
   LI
   LO
   TS
CL001063 T47D-KBluc Homo sapiens (Human)  1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 2.1 nM
2 IC50 = 2.24 nM
3 IC50 = 7.5 nM
Protein ID: PT00889, Estrogen receptor beta
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000043 U2OS Homo sapiens (Human)  1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 1.68 nM
Protein ID: PT06109, Geminin
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000015 SW480 Homo sapiens (Human)  1
1
Potency ~ 11582.1 nM
   TI
   LI
   LO
   TS
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000156 HT-1080 Homo sapiens (Human)  1
1
Potency ~ 16360.1 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Afimoxifene )
Drug Name Afimoxifene
Company ASCEND Therapeutics
Indication
Breast cancer
Phase 2
Ductal carcinoma
Phase 2
Target(s)
Estrogen receptor (ESR)
Modulator